24/7 Customer Assistance
24/7 Assistance with the best medical care at your service
Call us for any question
+91 90858 83067BLOCK-B, PH-1, Sushant Lok Phase I, Gurugram, Haryana 122001
IndiaOffice Hour: 09:00am - 09:00pm
info@medigocare.comIf you're reading this, chances are you or someone you love is facing a cancer diagnosis — and you're trying to figure out what comes next. We've helped hundreds of patients from Nigeria, Bangladesh, the UAE, Kenya, Nepal, and the UK go through this exact process. And we know how overwhelming it feels.
Here's what we've found: India is, right now, one of the best places in the world for cancer treatment — not just because of the cost, but because of the quality, speed, and access to advanced therapies that are either unavailable or unaffordable elsewhere.
This guide covers everything you need to know. Costs. Hospitals. Treatments. The visa process. What's included in our package. And what to expect, step by step.
Let's get into it.
India has become the top choice for cancer treatment in India for international patients — and it's not just about saving money. The country now handles over 700,000 international medical tourists annually, according to WHO data, with oncology being the fastest-growing segment.
But why India specifically? Three reasons stand out every single time: cost, quality, and how fast you can actually get treated.
Here's the raw data. No fluff.
| Treatment | India (USD) | USA (USD) | UK (GBP) | Thailand (USD) | Savings vs USA |
|---|---|---|---|---|---|
| Bone Marrow Transplant (Allogeneic) | $15,000–$25,000 | $250,000–$350,000 | £80,000–£120,000 | $35,000–$60,000 | Up to 90% |
| CAR-T Cell Therapy | $45,000–$100,000 | $400,000–$500,000 | £250,000+ | Not widely available | Up to 88% |
| HIPEC Surgery | $10,000–$22,000 | $60,000–$120,000 | £40,000–£70,000 | $20,000–$40,000 | Up to 83% |
| Robotic Cancer Surgery | $6,000–$14,000 | $30,000–$80,000 | £20,000–£50,000 | $12,000–$25,000 | Up to 80% |
| Chemotherapy (per cycle) | $420–$1,200 | $5,000–$15,000 | £2,000–£8,000 | $1,500–$4,000 | Up to 85% |
Sources: WHO, NCI, ICMR, hospital-verified data 2026
So yes — a bone marrow transplant that costs $300,000 in the USA can be done in India for $15,000–$25,000. That's not a typo.
Many people ask us: "But is the quality actually good?" It's a fair question. And the answer is — at India's top hospitals, absolutely yes.
Apollo Hospitals, Tata Memorial Centre, and Medanta are JCI (Joint Commission International) and NABH accredited. These are the same global standards that leading hospitals in the US and UK must meet. Moreover, a large number of Indian oncologists completed their post-graduation and fellowship training at institutions in the UK, USA, or Germany. They came back to India — and brought that expertise with them.
Per JCI accreditation data, India has the highest number of JCI-accredited hospitals in Asia. That's not a small thing.
This is the part that surprises most of our UK diaspora patients the most.
On the NHS, the average wait time for cancer treatment can be 3 to 6 months — even for urgent cases. In India, most treatment programmes begin within 10 to 14 days of your arrival. For aggressive cancers like AML or Stage III lymphoma, waiting is not an option. Every week counts.
We've had patients from Birmingham and Manchester who flew to India, completed their first chemotherapy cycle, and flew back — all before they would have even had their first NHS oncologist appointment.
We work with oncology departments across India's top hospitals. Together, we handle the full spectrum — from common solid tumours to rare and advanced-stage cancers that many facilities won't even touch.
Blood cancer treatment in India covers all major subtypes: ALL (Acute Lymphoblastic Leukemia), AML (Acute Myeloid Leukemia), CML, CLL, Hodgkin and Non-Hodgkin Lymphoma, and Multiple Myeloma. India's BMT centres — particularly at Tata Memorial and Medanta — report outcomes comparable to Western centres, per ICMR National Cancer Registry data.
For leukemia treatment in India and bone marrow cancer treatment, we coordinate directly with haematology-oncology teams to ensure fast-track case review.
India's hospitals handle high volumes of solid tumour cases — which means deep experience. Breast cancer treatment in India is one of our most requested services, with options ranging from breast-conserving surgery to robotic mastectomy and targeted therapy protocols. Liver, colon, head and neck, and cervical cancers are all managed with multidisciplinary tumour boards reviewing each case.
Liver cancer treatment in India has seen particular advances with the adoption of laparoscopic and robotic hepatectomy at centres like Apollo Chennai and Medanta Gurugram.
For patients with peritoneal cancer, appendix tumours, or neuroblastoma — India now offers HIPEC (Hyperthermic Intraperitoneal Chemotherapy), a specialised procedure available at only a handful of centres globally. We have direct access to these programmes. Read our detailed HIPEC Surgery India — International Patient Guide for more.
This is where India has really moved ahead of most countries in the past three years. Access to cutting-edge oncology is no longer reserved for wealthy Western hospitals. India now offers all four major advanced treatments — at a fraction of the price.
A Bone Marrow Transplant — or stem cell transplant — is the standard treatment for leukemia, lymphoma, aplastic anaemia, and multiple myeloma when other treatments aren't enough. In India, costs start at around ₹12.5 lakh (~$15,000) for an autologous BMT and go up to ₹45 lakh (~$55,000) for a complex allogeneic (donor) BMT. That's 80–90% less than the USA.
Tata Memorial Centre in Mumbai and Medanta in Gurugram have among the highest BMT success rates in Asia, per PubMed-indexed BMT outcome studies from Indian institutions. We handle everything — from donor search coordination to post-transplant care planning.
Read our full guide: Bone Marrow Transplant in India — Full Cost & Success Rate Guide
CAR-T cell therapy is one of the most exciting breakthroughs in cancer medicine. It reprograms your own immune cells to hunt and destroy cancer cells. Until recently, it was only available in the USA and Europe — for $400,000 to $500,000.
India changed that in 2023 with the launch of NexCAR19 — the world's first indigenously developed CAR-T therapy, approved by India's Central Drugs Standard Control Organisation (CDSCO). As of 2026, it's available at Medanta Gurugram, Apollo Chennai, and a handful of other specialised centres. The cost? $45,000–$100,000 — roughly 75–88% less than the USA.
Per the NCI's overview of CAR-T treatment, this therapy has shown remission rates above 70% in relapsed/refractory B-cell lymphoma and ALL. India is now one of the few places in the world where this is truly accessible.
Get the full breakdown: CAR-T Cell Therapy India — Complete Guide
HIPEC — Hyperthermic Intraperitoneal Chemotherapy — combines tumour-removing surgery (cytoreductive surgery) with heated chemotherapy delivered directly into the abdominal cavity. It's used for peritoneal cancers, appendix cancers, and selected ovarian and colon cancer cases.
In India, this costs $10,000–$22,000. In the USA, the same procedure costs $60,000–$120,000. India has a limited number of HIPEC-trained surgical teams — and we work directly with those teams at Apollo and Medanta.
Full details here: HIPEC Surgery India — International Patient Guide
The da Vinci robotic surgical system offers far greater precision than open surgery — smaller cuts, less blood loss, faster recovery, and lower infection risk. India's top hospitals have da Vinci systems and surgeons who've performed thousands of procedures with them.
Robotic cancer surgery in India costs $6,000–$14,000 depending on the cancer type and complexity. Comparable procedures in the UK run £20,000–£50,000. We've guided patients through robotic prostatectomy, robotic gastrectomy, and robotic thoracic surgery — all in India.
Explore more: Robotic Cancer Surgery India — Da Vinci Outcomes & Cost
India doesn't have just one great cancer hospital. It has several — each with distinct strengths. Here's our honest assessment of the top three we work with most closely.
| Hospital | City | Speciality | Accreditation | International Desk |
|---|---|---|---|---|
| Tata Memorial Centre | Mumbai | Blood cancers, BMT, paediatric cancers | NABH, Government | Yes |
| Apollo Hospitals | Delhi / Chennai | All cancers, robotic surgery, BMT | JCI, NABH | Yes |
| Medanta – The Medicity | Gurugram | CAR-T, BMT, robotic surgery | JCI, NABH | Yes |
| Max Super Speciality Hospital | Delhi | Solid tumours, haematology | NABH | Yes |
| Fortis Memorial Research Institute | Gurugram | Surgical oncology, radiation | JCI, NABH | Yes |
Established in 1941, Tata Memorial Centre (TMC) is India's — and Asia's — premier cancer institute. It handles more than 70,000 patients annually, including a significant number of international cases. TMC has dedicated Bone Marrow Transplant, Radiation Oncology, and Surgical Oncology departments.
Their paediatric oncology department handles retinoblastoma, neuroblastoma, and leukaemia in children with some of the best outcomes in Asia. For patients from Nigeria, Bangladesh, and East Africa who can't afford Western prices, TMC has historically offered treatment at genuinely accessible costs, especially for public-sector patients.
Apollo is India's largest private hospital chain and one of the highest-volume oncology providers in Asia. Both its Delhi (Indraprastha) and Chennai campuses are JCI accredited. Apollo's oncology division operates a full da Vinci robotic surgery suite, a dedicated Bone Marrow Transplant unit, and one of India's most active proton therapy programmes.
We've placed patients from the UAE, UK, and Kenya at Apollo — and the international patient desk experience is genuinely smooth. Airport pick-up, interpreter service, and a dedicated case manager are all standard.
Medanta is located in Gurugram — just 15 minutes from MediGoCare's office. That makes coordination seamless for our team. Medanta is one of India's only hospitals currently offering NexCAR19 CAR-T cell therapy, and its Bone Marrow Transplant centre ranks among the top three in North India.
For international patients needing CAR-T therapy or a complex allogeneic BMT, Medanta is our first recommendation — not just because of proximity but because of the depth of their haematology programme.
Let's be completely transparent about the numbers. Here's a full cost table covering the ten most common cancer types treated in India.
| Cancer Type | Total Treatment Range (USD) | USA Equivalent (USD) | Savings |
|---|---|---|---|
| Breast Cancer (Surgery + Chemo) | $5,000–$12,000 | $50,000–$150,000 | 70–92% |
| Leukemia (AML/ALL with BMT) | $15,000–$30,000 | $250,000–$400,000 | 85–94% |
| Lymphoma (Chemo + Immunotherapy) | $8,000–$20,000 | $70,000–$180,000 | 75–89% |
| Lung Cancer (Surgery + Radiation) | $6,000–$15,000 | $40,000–$100,000 | 70–85% |
| Liver Cancer (Resection / TACE) | $7,000–$18,000 | $50,000–$120,000 | 70–86% |
| Colon Cancer (Robotic Surgery + Chemo) | $7,000–$16,000 | $50,000–$130,000 | 72–87% |
| Prostate Cancer (Robotic) | $5,500–$12,000 | $30,000–$60,000 | 68–82% |
| Cervical Cancer (Surgery + Radiation) | $5,000–$11,000 | $40,000–$90,000 | 70–87% |
| Peritoneal Cancer (HIPEC) | $10,000–$22,000 | $60,000–$120,000 | 75–83% |
| Blood Cancer CAR-T (NexCAR19) | $45,000–$100,000 | $400,000–$500,000 | 78–88% |
*All figures are approximate and depend on cancer stage, hospital tier, and treatment protocol. MediGoCare provides free personalised cost estimates based on your medical records.
When we say we handle everything — we mean it. Our coordination package typically includes:
We believe in transparency. So here are the additional costs you should be aware of:
There are no surprises when you work with us. We send you a full cost estimate in writing before you book your flights.
The process is simpler than most people expect. Here's how it works — from first contact to the day you fly home.
Step 1 — Send us your records. Contact MediGoCare on WhatsApp (+91 90858 83067) or email (info@medigocare.com). Share your diagnosis, recent reports, scans, and biopsy results. Everything stays confidential.
Step 2 — We review and respond within 48 hours. Our team shortlists the right hospitals for your case and sends you a personalised treatment plan with cost estimates. There's no obligation and no payment at this stage.
Patients from Nigeria, Bangladesh, Kenya, and UAE typically do this entire step remotely — before they've even booked a flight.
Step 3 — Visa. India's e-Medical Visa is available to citizens of 160+ countries. Apply online at indianvisaonline.gov.in. You'll need your passport, hospital invitation letter (we provide this), medical records, and a passport-sized photograph. Approval typically takes 3–5 business days. The visa is valid for 60 days with triple entry — extendable to 6 months for longer treatments.
Up to two family members can travel with you on a Medical Attendant Visa, linked to your patient visa.
Step 4 — Travel & Transfer. Once your visa arrives, our team coordinates your flight timing with the hospital's appointment calendar. Our driver meets you at the airport — no need to figure out transfers in an unfamiliar city.
Step 5 — Treatment begins. Your dedicated MediGoCare coordinator is with you through every consultation, procedure, and follow-up during your stay. We handle all translation needs and hospital communication.
Step 6 — Recovery & clearance. Before you fly home, the hospital issues a fit-to-fly certificate — a formal medical clearance document. We also arrange your discharge summary, translated medical reports, and a tele-consultation schedule with your Indian oncologist for the first 3 months post-treatment.
The questions below are based on what patients actually ask us — on WhatsApp, by email, and in Google searches. We've answered every one of them honestly.
Yes — at India's top hospitals, absolutely. Tata Memorial, Apollo, and Medanta are JCI and NABH accredited and follow the same oncology protocols, surgical standards, and drug regimens as leading UK and US hospitals. Many senior Indian oncologists trained at institutions like Harvard, Johns Hopkins, or the Royal Marsden. India also has over 4,000 certified oncologists — one of the largest oncology workforces in the world. The difference is cost and wait time, not quality.
Apply for an e-Medical Visa at indianvisaonline.gov.in. You'll need your passport, a hospital invitation letter (MediGoCare provides this free), your recent medical records, and a passport photo. Approval takes 3–5 business days in most cases. The visa allows triple entry over 60 days — extendable up to 6 months for longer treatments. Per India's Ministry of Health guidelines, the e-Medical Visa is specifically designed for international patients and is separate from the tourist visa.
For blood cancers — including leukemia, lymphoma, and multiple myeloma — Tata Memorial Centre Mumbai, Medanta Gurugram, and Apollo Delhi consistently report the best outcomes. Tata Memorial handles over 70,000 patients annually and is recognised as one of Asia's top BMT centres. For CAR-T cell therapy specifically, Medanta is currently the most active centre in India for the NexCAR19 protocol. ICMR data confirms that India's top centres now match international 5-year survival benchmarks for several blood cancer subtypes.
It depends on the treatment, but here are realistic timelines:
MediGoCare provides a personalised treatment timeline before you book travel — so you can plan your stay, caregiver arrangements, and work or school leave accordingly.
India's costs are the most competitive globally. Bone Marrow Transplant is 70–90% cheaper than USA. CAR-T costs $45,000–$100,000 vs $400,000+ in the USA. Chemotherapy cycles run $420–$1,200 vs $5,000–$15,000 in the USA. The WHO's global cancer data confirms India handles one of the world's highest patient volumes at consistently lower costs. MediGoCare provides written cost estimates at no charge — based on your actual diagnosis and records.
Yes. Most hospitals accommodate 1–2 family caregivers, and MediGoCare's packages include arrangements for family members. We help with accommodation near the hospital, caregiver support services, and attendant visa documentation. For long-stay treatments like BMT or CAR-T, having a caregiver present is genuinely important — both emotionally and practically. The Medical Attendant Visa allows up to two family members to accompany you, and it's linked directly to your patient visa application.
Yes — and this is something we take seriously. MediGoCare coordinates remote follow-up care including tele-consultations with your Indian oncologist, interpretation of follow-up lab reports and imaging, and coordination with your local oncologist for continuity of care. Many of our patients have quarterly video consultations with their Indian specialist for 12–24 months post-treatment. You don't just leave India and lose access to your care team.
Yes. India launched its own CAR-T therapy — NexCAR19 — in 2023, approved by the CDSCO (India's equivalent of the US FDA). It's currently available at Medanta Gurugram, Apollo Chennai, and a few other centres. Clinical trial data shows remission rates above 70% in relapsed B-cell lymphoma and ALL. Per the NCI's treatment overview, CAR-T is considered a standard treatment option for certain blood cancers. India's version is manufactured domestically, which is why it costs 75–88% less than the USA version.
You'll need: your most recent pathology report (biopsy), CT/MRI/PET-CT scan images and reports (on CD or digital), blood test reports from the past 3 months, a letter from your treating doctor summarising your case, your passport (and your attendant's passport), and your e-Medical Visa approval. MediGoCare provides a detailed checklist specific to your cancer type during the initial consultation.
MediGoCare is a medical tourism facilitation company. We receive a coordination fee from our hospital partners — not from patients. So our case management, consultation matching, visa letter, airport transfer, and accommodation coordination services involve no direct charge to patients beyond the hospital treatment costs. This model allows us to give honest hospital recommendations based on patient need, not on which hospital pays more.
Yes — these are two of our most active patient corridors. Nigeria and Bangladesh are among the top five source countries for medical tourists coming to India. Many patients from Lagos, Abuja, Dhaka, and Chittagong come to India specifically for blood cancer treatment and bone marrow transplants. Indian hospitals are well-experienced with these patient groups. MediGoCare has coordinators fluent in relevant languages and cultural contexts who help the journey feel less foreign.
We're honest with our patients from the start. MediGoCare helps you understand realistic outcomes based on your specific cancer type and stage before you travel. If a treatment plan needs to be modified mid-course — which can happen in oncology — our coordinator works closely with the hospital's multidisciplinary team to adjust the approach. We also help with second opinion arrangements at an alternate Indian hospital if needed. What we don't do is give false hope or oversell outcomes.
We're based in Gurugram (Gurgaon), Haryana — right next to Medanta, Artemis, and Fortis hospitals. That's not coincidental. Being physically close to the hospitals we work with means our coordinators can walk into a department, escalate an issue, or attend a patient meeting in person.
We're not a call centre. We're not a booking platform. We're a team of medical tourism professionals who've personally navigated Indian hospitals with foreign patients — and know exactly what can go wrong, and how to fix it.
Also explore all our Cancer Treatment India services →
In our experience, the patients who get the best outcomes are the ones who come with complete medical records, realistic expectations, and a support person. We've worked with a 34-year-old teacher from Lagos with AML who completed her bone marrow transplant at Medanta and returned to Nigeria in remission. We've also worked with a 58-year-old businessman from Dhaka who flew to Chennai for robotic liver resection — and was back home in 22 days.
These aren't exceptional cases. They're examples of what good planning and the right hospital matching makes possible.
India is the right choice if: you're facing a cancer diagnosis that requires advanced treatment, costs in your home country are prohibitive, NHS or public health wait times are too long, you need access to CAR-T, BMT, HIPEC, or robotic surgery, and you want a care team that handles the entire journey for you.
India is not a compromise. At the right hospital, with the right team managing your case, the outcomes are world-class. We've seen it dozens of times.
But none of this happens on its own. You need a coordinator who knows India's oncology landscape and can match you to the right hospital, the right doctor, and the right protocol for your specific case.
That's what we do.
24/7 Assistance with the best medical care at your service
Quality treatment with professional & unmatched personal care
Our experts make your Communication easier and more transparent